These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 24090110

  • 1. Ligand binding determinants for angiotensin II type 1 receptor from computer simulations.
    Matsoukas MT, Cordomí A, Ríos S, Pardo L, Tselios T.
    J Chem Inf Model; 2013 Nov 25; 53(11):2874-83. PubMed ID: 24090110
    [Abstract] [Full Text] [Related]

  • 2. Insights into AT1 receptor activation through AngII binding studies.
    Matsoukas MT, Potamitis C, Plotas P, Androutsou ME, Agelis G, Matsoukas J, Zoumpoulakis P.
    J Chem Inf Model; 2013 Nov 25; 53(11):2798-811. PubMed ID: 24053563
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Reliability of Docking-Based Virtual Screening for GPCR Ligands with Homology Modeled Structures: A Case Study of the Angiotensin II Type I Receptor.
    Chen H, Fu W, Wang Z, Wang X, Lei T, Zhu F, Li D, Chang S, Xu L, Hou T.
    ACS Chem Neurosci; 2019 Jan 16; 10(1):677-689. PubMed ID: 30265513
    [Abstract] [Full Text] [Related]

  • 5. The impact of molecular dynamics sampling on the performance of virtual screening against GPCRs.
    Tarcsay A, Paragi G, Vass M, Jójárt B, Bogár F, Keserű GM.
    J Chem Inf Model; 2013 Nov 25; 53(11):2990-9. PubMed ID: 24116387
    [Abstract] [Full Text] [Related]

  • 6. Structural determinants of subtype selectivity and functional activity of angiotensin II receptors.
    Sallander J, Wallinder C, Hallberg A, Åqvist J, Gutiérrez-de-Terán H.
    Bioorg Med Chem Lett; 2016 Feb 15; 26(4):1355-9. PubMed ID: 26810314
    [Abstract] [Full Text] [Related]

  • 7. Application of Multiscale Simulation Tools on GPCRs. An Example with Angiotensin II Type 1 Receptor.
    Erol I, Aksoydan B, Kantarcioglu I, Durdagi S.
    Methods Mol Biol; 2018 Feb 15; 1824():431-448. PubMed ID: 30039423
    [Abstract] [Full Text] [Related]

  • 8. Angiotensin II Type 1 Receptor Homology Models: A Comparison Between In Silico and the Crystal Structures.
    Kellici TF.
    Methods Mol Biol; 2018 Feb 15; 1824():449-460. PubMed ID: 30039424
    [Abstract] [Full Text] [Related]

  • 9. Angiotensin II cyclic analogs as tools to investigate AT1R biased signaling mechanisms.
    St-Pierre D, Cabana J, Holleran BJ, Besserer-Offroy É, Escher E, Guillemette G, Lavigne P, Leduc R.
    Biochem Pharmacol; 2018 Aug 15; 154():104-117. PubMed ID: 29684376
    [Abstract] [Full Text] [Related]

  • 10. Molecular modeling of adenosine receptors.
    Martinelli A, Ortore G.
    Methods Enzymol; 2013 Aug 15; 522():37-59. PubMed ID: 23374179
    [Abstract] [Full Text] [Related]

  • 11. Structure of the human angiotensin II type 1 (AT1) receptor bound to angiotensin II from multiple chemoselective photoprobe contacts reveals a unique peptide binding mode.
    Fillion D, Cabana J, Guillemette G, Leduc R, Lavigne P, Escher E.
    J Biol Chem; 2013 Mar 22; 288(12):8187-8197. PubMed ID: 23386604
    [Abstract] [Full Text] [Related]

  • 12. Divergent Spatiotemporal Interaction of Angiotensin Receptor Blocking Drugs with Angiotensin Type 1 Receptor.
    Singh KD, Unal H, Desnoyer R, Karnik SS.
    J Chem Inf Model; 2018 Jan 22; 58(1):182-193. PubMed ID: 29195045
    [Abstract] [Full Text] [Related]

  • 13. Trans and Cis Conformations of the Antihypertensive Drug Valsartan Respectively Lock the Inactive and Active-like States of Angiotensin II Type 1 Receptor: A Molecular Dynamics Study.
    Wang L, Yan F.
    J Chem Inf Model; 2018 Oct 22; 58(10):2123-2130. PubMed ID: 30212210
    [Abstract] [Full Text] [Related]

  • 14. Evolution of Angiotensin Peptides and Peptidomimetics as Angiotensin II Receptor Type 2 (AT2) Receptor Agonists.
    Vasile S, Hallberg A, Sallander J, Hallberg M, Åqvist J, Gutiérrez-de-Terán H.
    Biomolecules; 2020 Apr 23; 10(4):. PubMed ID: 32340100
    [Abstract] [Full Text] [Related]

  • 15. Structure prediction of GPCRs using piecewise homologs and application to the human CCR5 chemokine receptor: validation through agonist and antagonist docking.
    Arumugam K, Crouzy S, Chevigne A, Seguin-Devaux C, Schmit JC.
    J Biomol Struct Dyn; 2014 Apr 23; 32(8):1274-89. PubMed ID: 23869548
    [Abstract] [Full Text] [Related]

  • 16. Development of CoMFA models of affinity and selectivity to angiotensin II type-1 and type-2 receptors.
    Sköld C, Karlén A.
    J Mol Graph Model; 2007 Jul 23; 26(1):145-53. PubMed ID: 17161636
    [Abstract] [Full Text] [Related]

  • 17. Leveraging NMR and X-ray Data of the Free Ligands to Build Better Drugs Targeting Angiotensin II Type 1 G-Protein Coupled Receptor.
    Kellici TF, Ntountaniotis D, Kritsi E, Zervou M, Zoumpoulakis P, Potamitis C, Durdagi S, Salmas RE, Ergun G, Gokdemir E, Halabalaki M, Gerothanassis IP, Liapakis G, Tzakos A, Mavromoustakos T.
    Curr Med Chem; 2016 Jul 23; 23(1):36-59. PubMed ID: 26572611
    [Abstract] [Full Text] [Related]

  • 18. From heptahelical bundle to hits from the Haystack: structure-based virtual screening for GPCR ligands.
    Kooistra AJ, Roumen L, Leurs R, de Esch IJ, de Graaf C.
    Methods Enzymol; 2013 Jul 23; 522():279-336. PubMed ID: 23374191
    [Abstract] [Full Text] [Related]

  • 19. Structural basis of the interactions between CXCR4 and CXCL12/SDF-1 revealed by theoretical approaches.
    Xu L, Li Y, Sun H, Li D, Hou T.
    Mol Biosyst; 2013 Aug 23; 9(8):2107-17. PubMed ID: 23702796
    [Abstract] [Full Text] [Related]

  • 20. Insights into the binding modes of CC chemokine receptor 4 (CCR4) inhibitors: a combined approach involving homology modelling, docking, and molecular dynamics simulation studies.
    Gadhe CG, Kim MH.
    Mol Biosyst; 2015 Feb 23; 11(2):618-34. PubMed ID: 25474265
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.